12:00 AM
 | 
Mar 10, 2014
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Synta preclinical data

In mouse xenograft models of triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC), 50 mg/kg STA-9183 safely delivered docetaxel at up to 7 times greater unconjugated docetaxel. Specifically, 50 mg/kg STA-9183 safely delivered docetaxel at a dosage equivalent to 28...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >